在BRCA1/2突变载体中减少卵巢癌风险和查
Jessica B DiSilvestro1, Jessica Haddad2, Katina Robison1
1Department of Obstetrics-Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, Rhode Island, USA.
Journal of women's health (2002)
|March 15, 2024
概括
女性BRCA1/2携带者接受了降低风险的手术,但接受药物治疗或卵巢癌查的人少. 需要进一步的研究来了解高风险妇女中这些预防策略的障碍.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 预防医学 预防医学
背景情况:
- BRCA1/2突变显著增加卵巢癌的风险.
- 风险降低策略和查对于早期检测和预防至关重要.
- 了解使用模式可以为高风险个体的临床实践提供信息.
研究的目的:
- 评估风险降低策略和卵巢癌查方案的采用情况.
- 评估影响女性BRCA1/2携带者使用这些预防措施的因素.
- 确定实施卵巢癌风险管理的潜在障碍.
主要方法:
- 在女性BRCA1/2突变携带者中进行了一项多中心的横截面调查.
- 电子问卷收集了关于降低风险的手术,药物 (组合口服避孕药) 和查的数据.
- 用费舍尔精确测试分析数据,以比较利用率.
主要成果:
- 几乎所有参与者 (97.1%) 与提供者讨论了降低风险的手术.
- 在45岁前接受测试的女性中,53.2%被建议服用联合口服避孕药 (COCs) 来降低风险,其中88.1%使用这些避孕药.
- 大约一半 (55.8%) 接受了增加的卵巢癌查,81.0%接受了查,通常是通过阴道超声波和CA125.5进行查.
- 在基因检测中,年轻女性的COC推率更高 (p < 0.0001).
结论:
- 虽然降低风险的手术被广泛提供,但降低风险的药物和查吸收率在BRCA1/2携带者中较低.
- 基因测试时的年龄会影响组合口服避孕药的推和使用.
- 在这种高风险人群中使用降低风险策略的障碍需要进一步调查.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.3K
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
14.7K
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
